Invesco’s GenMark Diagnostics, Inc GNMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-25,424
| Closed | -$608K | – | 4114 |
|
|
2021
Q1 | $608K | Buy |
25,424
+10,639
| +72% | +$198K | ﹤0.01% | 3265 |
|
|
2020
Q4 | $216K | Sell |
14,785
-779,656
| -98% | -$10.3M | ﹤0.01% | 3521 |
|
|
2020
Q3 | $11.3M | Buy |
+794,441
| New | +$12.1M | ﹤0.01% | 1600 |
|
|
2019
Q2 | – | Sell |
-26,094
| Closed | -$185K | – | 3814 |
|
|
2019
Q1 | $185K | Buy |
26,094
+1,473
| +6% | +$9.7K | ﹤0.01% | 3635 |
|
|
2018
Q4 | $120K | Sell |
24,621
-4,989
| -17% | -$26K | ﹤0.01% | 3626 |
|
|
2018
Q3 | $218K | Buy |
29,610
+7,242
| +32% | +$53.1K | ﹤0.01% | 3679 |
|
|
2018
Q2 | $143K | Buy |
+22,368
| New | +$148K | ﹤0.01% | 3748 |
|
|
2017
Q3 | – | Sell |
-60,919
| Closed | -$721K | – | 3686 |
|
|
2017
Q2 | $721K | Buy |
+60,919
| New | +$779K | ﹤0.01% | 3191 |
|
|
2017
Q1 | – | Sell |
-69,747
| Closed | -$854K | – | 3779 |
|
|
2016
Q4 | $854K | Buy |
+69,747
| New | +$828K | ﹤0.01% | 3079 |
|
|
2015
Q3 | – | Sell |
-6,364
| Closed | -$58K | – | 4100 |
|
|
2015
Q2 | $58K | Buy |
+6,364
| New | +$64.2K | ﹤0.01% | 3963 |
|
|
2013
Q4 | – | Sell |
-12,305
| Closed | -$149K | – | 4389 |
|
|
2013
Q3 | $149K | Buy |
12,305
+4,071
| +49% | +$43.6K | ﹤0.01% | 3873 |
|
|
2013
Q2 | $85K | Buy |
+8,234
| New | +$114K | ﹤0.01% | 3991 |
|
Invesco's GNMK Position: Q2 2021 in Review
Invesco sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 25,424 shares — an estimated $608K sold.
Invesco first reported a position in GNMK in Q2 2013 and held it in 12 quarters. The position peaked at $11.3M in Q3 2020. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.
- Invesco reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
- Invesco sold 25,424 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $608K.
- Invesco first reported a position in GenMark Diagnostics, Inc in Q2 2013 and held it in 12 quarters.
- Invesco's GenMark Diagnostics, Inc position peaked at $11.3M in Q3 2020.
- 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.
Based on Invesco's 13F filing for Q2 2021, filed 17 Aug 2021.